1	Increased	increase	_	_	_	_	_	_	_
2	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
3	receptor	receptor	_	_	_	_	_	_	_
4	beta	beta	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	airway	airway	_	_	_	_	_	_	_
7	cells	cell	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	glucocorticoid-insensitive	glucocorticoid-insensitive	_	_	_	_	_	_	_
10	asthma	asthma	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Glucocorticoid	Glucocorticoid	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	GC)-insensitive	gc)-insensitive	_	_	_	_	_	_	_
4	asthma	asthma	_	_	_	_	_	_	_
5	is	be	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	challenging	challenging	_	_	_	_	_	_	_
8	clinical	clinical	_	_	_	_	_	_	_
9	problem	problem	_	_	_	_	_	_	_
10	that	that	_	_	_	_	_	_	_
11	can	can	_	_	_	_	_	_	_
12	be	be	_	_	_	_	_	_	_
13	associated	associate	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	life-threatening	life-threatening	_	_	_	_	_	_	_
16	disease	disease	_	_	_	_	_	_	_
17	progression	progression	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	molecular	molecular	_	_	_	_	_	_	_
3	basis	basis	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	GC	GC	_	_	_	_	_	_	_
6	insensitivity	insensitivity	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	unknown	unknown	_	_	_	_	_	_	_
9	.	.	_	_	_	_	_	_	_

1	Alternative	alternative	_	_	_	_	_	_	_
2	splicing	splicing	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	GC	GC	_	_	_	_	_	_	_
6	receptor	receptor	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	GCR	GCR	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	pre-mRNA	pre-mRNA	_	_	_	_	_	_	_
11	generates	generate	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	second	second	_	_	_	_	_	_	_
14	GCR	gcr	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	termed	term	_	_	_	_	_	_	_
17	GCRbeta	GCRbeta	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	which	which	_	_	_	_	_	_	_
20	does	do	_	_	_	_	_	_	_
21	not	not	_	_	_	_	_	_	_
22	bind	bind	_	_	_	_	_	_	_
23	GC	GC	_	_	_	_	_	_	_
24	but	but	_	_	_	_	_	_	_
25	antagonizes	antagonize	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	transactivating	transactivating	_	_	_	_	_	_	_
28	activity	activity	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	classic	classic	_	_	_	_	_	_	_
32	GCR	gcr	_	_	_	_	_	_	_
33	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	increased	increase	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	GCRbeta	GCRbeta	_	_	_	_	_	_	_
6	could	could	_	_	_	_	_	_	_
7	account	account	_	_	_	_	_	_	_
8	for	for	_	_	_	_	_	_	_
9	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
10	insensitivity	insensitivity	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Bronchoalveolar	bronchoalveolar	_	_	_	_	_	_	_
2	lavage	lavage	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	BAL	BAL	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	peripheral	peripheral	_	_	_	_	_	_	_
9	blood	blood	_	_	_	_	_	_	_
10	mononuclear	mononuclear	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	(	(	_	_	_	_	_	_	_
13	PBMC	PBMC	_	_	_	_	_	_	_
14	)	)	_	_	_	_	_	_	_
15	were	be	_	_	_	_	_	_	_
16	examined	examine	_	_	_	_	_	_	_
17	for	for	_	_	_	_	_	_	_
18	GCRbeta	GCRbeta	_	_	_	_	_	_	_
19	immunoreactivity	immunoreactivity	_	_	_	_	_	_	_
20	using	use	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	GCRbeta-specific	gcrbeta-specific	_	_	_	_	_	_	_
23	antibody	antibody	_	_	_	_	_	_	_
24	by	by	_	_	_	_	_	_	_
25	immunohistochemical	immunohistochemical	_	_	_	_	_	_	_
26	staining	staining	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Cell	cell	_	_	_	_	_	_	_
2	localization	localization	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	GCRbeta	GCRbeta	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	was	be	_	_	_	_	_	_	_
7	performed	perform	_	_	_	_	_	_	_
8	using	use	_	_	_	_	_	_	_
9	a	a	_	_	_	_	_	_	_
10	double	double	_	_	_	_	_	_	_
11	immunostaining	immunostaining	_	_	_	_	_	_	_
12	technique	technique	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	Patients	patient	_	_	_	_	_	_	_
2	with	with	_	_	_	_	_	_	_
3	GC-insensitive	gc-insensitive	_	_	_	_	_	_	_
4	asthma	asthma	_	_	_	_	_	_	_
5	expressed	express	_	_	_	_	_	_	_
6	a	a	_	_	_	_	_	_	_
7	significantly	significantly	_	_	_	_	_	_	_
8	higher	high	_	_	_	_	_	_	_
9	number	number	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	GCRbeta-immunoreactive	gcrbeta-immunoreactive	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	their	their	_	_	_	_	_	_	_
15	BAL	bal	_	_	_	_	_	_	_
16	and	and	_	_	_	_	_	_	_
17	peripheral	peripheral	_	_	_	_	_	_	_
18	blood	blood	_	_	_	_	_	_	_
19	than	than	_	_	_	_	_	_	_
20	GC-sensitive	gc-sensitive	_	_	_	_	_	_	_
21	asthmatics	asthmatic	_	_	_	_	_	_	_
22	or	or	_	_	_	_	_	_	_
23	normal	normal	_	_	_	_	_	_	_
24	control	control	_	_	_	_	_	_	_
25	subjects	subject	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	GCRbeta	GCRbeta	_	_	_	_	_	_	_
4	expression	expression	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	GC-insensitive	gc-insensitive	_	_	_	_	_	_	_
7	asthma	asthma	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	particularly	particularly	_	_	_	_	_	_	_
10	high	high	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	airway	airway	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	which	which	_	_	_	_	_	_	_
17	are	be	_	_	_	_	_	_	_
18	thought	think	_	_	_	_	_	_	_
19	to	to	_	_	_	_	_	_	_
20	play	play	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	major	major	_	_	_	_	_	_	_
23	role	role	_	_	_	_	_	_	_
24	in	in	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	pathogenesis	pathogenesis	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	asthma	asthma	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	examined	examine	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	expression	expression	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	GCRbeta	GCRbeta	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	specimens	specimen	_	_	_	_	_	_	_
10	from	from	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	airways	airway	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	patients	patient	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	chronic	chronic	_	_	_	_	_	_	_
17	bronchitis	bronchitis	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	chronic	chronic	_	_	_	_	_	_	_
3	bronchitis	bronchitis	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	few	few	_	_	_	_	_	_	_
6	cells	cell	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	GCRbeta-positive	gcrbeta-positive	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	their	their	_	_	_	_	_	_	_
11	numbers	number	_	_	_	_	_	_	_
12	did	do	_	_	_	_	_	_	_
13	not	not	_	_	_	_	_	_	_
14	differ	differ	_	_	_	_	_	_	_
15	significantly	significantly	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	normal	normal	_	_	_	_	_	_	_
18	control	control	_	_	_	_	_	_	_
19	subjects	subject	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	conclude	conclude	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	GC-insensitive	gc-insensitive	_	_	_	_	_	_	_
5	asthma	asthma	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	associated	associate	_	_	_	_	_	_	_
8	with	with	_	_	_	_	_	_	_
9	increased	increase	_	_	_	_	_	_	_
10	expression	expression	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	GCRbeta	GCRbeta	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	airway	airway	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

